Pluxee (ENXTPA:PLX) has been sliding this year, with the share price down nearly 29% year to date, even as revenue and net income continue to edge higher. That disconnect is catching value investors ...
With Christmas a little over two weeks ago, one might be scrambling to find a gift for a loved one, friend, or family member. If you’re familiar with Arduino or Raspberry Pi and have a free weekend, ...
Parallax Worlds, a startup building hyper-realistic virtual simulations to stress-test robots before deployment, today announced it raised $4 million in a seed round. Developing and deploying robots ...
This delicious sweet potato bundt cake just might dethrone pumpkin pie as the top dessert of the holiday season. In this video, Matthew Francis shows you how to make this moist and naturally sweet ...
Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...
I’ve spent the past few years trying to understand something that often feels beyond understanding—how artificial intelligence, particularly large language models, actually thinks. Or at least, how ...
Qualcomm's acquisition gives it access to millions of developers in the Arduino ecosystem while also supporting its platform strategy for embedded devices, which now extends across hardware, software, ...
SAN FRANCISCO, Oct 7 (Reuters) - Qualcomm (QCOM.O), opens new tab on Tuesday said it has acquired Arduino, an Italian not-for-profit firm that makes hardware and software for developing prototypes of ...
Smartphone processor and modem maker Qualcomm is acquiring Arduino, the Italian company known mainly for its open source ecosystem of microcontrollers and the software that makes them function. In its ...
Protalix BioTherapeutics, Inc. (NYSEAMERICAN:PLX) is among the hidden penny stocks to buy now. During the first quarter, Goldman Sachs Group Inc. expanded its holdings in Protalix BioTherapeutics, Inc ...
Plexium has raised $60.1 million, providing an infusion of cash for the recently slimmed-down protein degrader specialist three years on from its breakout year. The biotech put itself on the map in ...